Remove 2026 Remove Leadership Remove Pharmaceuticals Remove Telehealth
article thumbnail

What's next for Digital Therapeutics after it all went PEAR shaped?

Lloyd Price

Billion valuation and loss of a development deal with Otsuka Pharmaceuticals. Partnership and collaboration: Healthcare providers, pharmaceutical companies, and technology companies are likely to form more partnerships and collaborations to develop and commercialize DTx solutions. billion by 2026, growing at a CAGR of 17.8%